
Jess Sharpe, Associate Consultant, L.E.K. Consulting
Advertisement

Jess Sharpe is an Associate Consultant in L.E.K.’s Life Sciences practice, based in the London Office. She supports projects across the pharmaceutical, biotech and digital health sectors, with a keen eye on the growth of psychedelics. Previously, Jess studied MSci Natural Sciences at the University of Cambridge, specialising in the History and Philosophy of Science.
Email: j.sharpe@lek.com
Articles by Jess Sharpe, Associate Consultant, L.E.K. Consulting

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: Gilead Acquires Oral IL-23R Inhibitor From PepStar for $1.275 Billion, Zymeworks Licenses DLL3-Targeting T Cell Engager to Roche
2
Treasury Proposes Rules Adding Biotechnology to Outbound Investment Security Program
3
FDA Approves Subcutaneous Induction for Skyrizi in Crohn's Disease
4
Pharmaceutical Executive Daily: Treasury Issues Notice to Add Biotech into Proposed COINS Act
5